[go: up one dir, main page]

EA201691607A1 - Микроорганоиды и способы их получения и применения - Google Patents

Микроорганоиды и способы их получения и применения

Info

Publication number
EA201691607A1
EA201691607A1 EA201691607A EA201691607A EA201691607A1 EA 201691607 A1 EA201691607 A1 EA 201691607A1 EA 201691607 A EA201691607 A EA 201691607A EA 201691607 A EA201691607 A EA 201691607A EA 201691607 A1 EA201691607 A1 EA 201691607A1
Authority
EA
Eurasian Patent Office
Prior art keywords
microorganoids
reception
methods
application
physiological
Prior art date
Application number
EA201691607A
Other languages
English (en)
Inventor
Цзя-Лунь ВАН
Мохит Б. БХАТИА
Роберт Дж. ХЭРИРИ
Вольфганг ХОФГАРТНЕР
Цянь Е
Original Assignee
Антродженезис Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Антродженезис Корпорейшн filed Critical Антродженезис Корпорейшн
Publication of EA201691607A1 publication Critical patent/EA201691607A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

Настоящее изобретение относится к микроорганоидам, именуемым здесь как Функциональные Физиологические Единицы (ФФЕ), которые способны заменять или усиливать одну или несколько физиологических функций у индивидуума и применимы для лечения индивидуумов, у которых указанная физиологическая функция отсутствует или является дефицитной.
EA201691607A 2014-02-11 2015-02-10 Микроорганоиды и способы их получения и применения EA201691607A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461938536P 2014-02-11 2014-02-11
PCT/US2015/015157 WO2015123183A1 (en) 2014-02-11 2015-02-10 Micro-organoids, and methods of making and using the same

Publications (1)

Publication Number Publication Date
EA201691607A1 true EA201691607A1 (ru) 2017-01-30

Family

ID=53800559

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201691607A EA201691607A1 (ru) 2014-02-11 2015-02-10 Микроорганоиды и способы их получения и применения

Country Status (11)

Country Link
US (2) US20160354408A1 (ru)
EP (1) EP3104865A4 (ru)
JP (3) JP2017507935A (ru)
KR (2) KR20170008723A (ru)
CN (1) CN106456669A (ru)
AU (2) AU2015217406A1 (ru)
CA (1) CA2939339C (ru)
EA (1) EA201691607A1 (ru)
HK (1) HK1232140A1 (ru)
MX (1) MX2016010293A (ru)
WO (1) WO2015123183A1 (ru)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9719068B2 (en) 2010-05-06 2017-08-01 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
CN106661548B (zh) 2014-05-28 2020-12-11 儿童医院医疗中心 用于经由定向分化将前体细胞转化为胃组织的方法和系统
AU2015306811A1 (en) * 2014-08-25 2017-03-09 Hli Cellular Therapeutics, Llc Extracellular matrix compositions
AU2015331848B2 (en) 2014-10-17 2022-03-03 Children's Hospital Medical Center, D/B/A Cincinnati Children's Hospital Medical Center In vivo model of human small intestine using pluripotent stem cells and methods of making and using same
CN106039421B (zh) * 2015-04-07 2018-06-12 四川蓝光英诺生物科技股份有限公司 一种包含内皮细胞的生物砖及其用途
TWI741980B (zh) * 2015-04-07 2021-10-11 大陸商四川藍光英諾生物科技股份有限公司 一種生物磚及其用途
WO2016161944A1 (en) 2015-04-07 2016-10-13 Sichuan Revotek Co., Ltd. Compositions for cell-based three dimensional printing
CN106606804B (zh) * 2015-10-22 2020-05-12 四川蓝光英诺生物科技股份有限公司 一种制备复合结构的方法
CN107261994B (zh) * 2016-04-07 2019-10-29 四川蓝光英诺生物科技股份有限公司 一种核-壳结构的制备方法
US11066650B2 (en) 2016-05-05 2021-07-20 Children's Hospital Medical Center Methods for the in vitro manufacture of gastric fundus tissue and compositions related to same
CN107432955B (zh) * 2016-09-14 2020-09-04 四川蓝光英诺生物科技股份有限公司 用于制备生物构建体的方法和试剂盒
US11439731B2 (en) 2016-09-14 2022-09-13 Revotek Co., Ltd. Artificial tissue progenitor and method for preparing the same
CN110062764B (zh) 2016-12-05 2024-07-02 儿童医院医学中心 结肠类器官及其制备和使用方法
WO2018170390A1 (en) * 2017-03-17 2018-09-20 Senti Biosciences, Inc. Immunomodulating cell circuits
EP3610000A1 (en) 2017-04-13 2020-02-19 Senti Biosciences, Inc. Combinatorial cancer immunotherapy
JP7248586B2 (ja) 2017-04-14 2023-03-29 チルドレンズ ホスピタル メディカル センター 複数ドナー幹細胞組成物およびそれを作製する方法
JP2020536529A (ja) 2017-10-10 2020-12-17 チルドレンズ ホスピタル メディカル センター 食道組織および／または臓器組成物およびそれを作製する方法
KR20210055027A (ko) * 2018-05-14 2021-05-14 루스터바이오, 인크. 고장성 세포 용액으로부터 유래된 세포외 물질과 관련된 방법 및 조성물
CN108660107B (zh) * 2018-05-21 2021-04-13 浙江大学 一种骨骼肌类器官构建方法
KR102103783B1 (ko) * 2018-06-21 2020-04-23 한국원자력의학원 침샘 조직의 탈세포화 세포외기질-하이드로겔 및 침샘 오거나이드를 제조하는 방법
US20210277360A1 (en) * 2018-07-16 2021-09-09 Kansas State University Research Foundation Cell linkers for heterotypic cell spheroids
JP2022512766A (ja) 2018-10-17 2022-02-07 センティ バイオサイエンシズ インコーポレイテッド 組み合わせがん免疫療法
US11419898B2 (en) 2018-10-17 2022-08-23 Senti Biosciences, Inc. Combinatorial cancer immunotherapy
CN111500533B (zh) * 2019-01-31 2024-07-16 华东理工大学 干细胞发生器及其构建方法
CN111494711B (zh) 2019-01-31 2023-06-23 华东理工大学 干细胞发生器产生的干细胞用于治疗造血损伤
KR102334245B1 (ko) * 2019-05-29 2021-12-03 연세대학교 산학협력단 인간 미뢰 오가노이드의 배양용 조성물
KR102179902B1 (ko) * 2019-08-08 2020-11-17 단국대학교 천안캠퍼스 산학협력단 상아모세포 분화용 지지체 및 이를 이용한 상아모세포로의 분화방법
CN113862154A (zh) * 2021-12-03 2021-12-31 东南大学苏州医疗器械研究院 用于器官组织三维培养的器官芯片及器官组织的培养方法
CN114807005B (zh) * 2022-04-09 2023-11-21 翌圣生物科技(上海)股份有限公司 使用动物尸体制备基质胶的方法
KR102577816B1 (ko) * 2022-06-08 2023-09-12 차의과학대학교 산학협력단 암 미세환경 모사 췌장암 오가노이드의 제조방법 및 이의 용도
KR20240088560A (ko) * 2022-12-13 2024-06-20 (주)차바이오텍 탯줄 유래 부착형 줄기세포를 포함하는 난소부전 예방 또는 치료용 약학적 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5523291A (en) * 1993-09-07 1996-06-04 Datascope Investment Corp. Injectable compositions for soft tissue augmentation
CA2665369C (en) * 2006-10-06 2023-01-10 Anthrogenesis Corporation Human placental collagen compositions, and methods of making and using the same
NZ617412A (en) * 2007-09-28 2015-06-26 Anthrogenesis Corp Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
WO2009102484A2 (en) * 2008-02-14 2009-08-20 Wake Forest University Health Sciences Inkjet printing of tissues and cells
GB201111244D0 (en) * 2011-06-30 2011-08-17 Konink Nl Akademie Van Wetenschappen Knaw Culture media for stem cells
US11786636B2 (en) * 2010-06-15 2023-10-17 Versitech Limited Methods for complex tissue engineering
EP2793912B1 (en) * 2011-12-23 2020-03-18 Celularity, Inc. Organoids comprising decellularized and repopulated placental vascular scaffold
MX2015002711A (es) * 2012-09-04 2015-06-05 Anthrogenesis Corp Metodos de generacion de tejidos.
JP2015529523A (ja) * 2012-09-04 2015-10-08 アントフロゲネシス コーポレーション 組織製造方法

Also Published As

Publication number Publication date
AU2020233611A1 (en) 2020-10-01
JP2020037561A (ja) 2020-03-12
KR20170008723A (ko) 2017-01-24
US20200246385A1 (en) 2020-08-06
KR20220093383A (ko) 2022-07-05
CA2939339C (en) 2023-03-14
AU2015217406A1 (en) 2016-08-25
CN106456669A (zh) 2017-02-22
WO2015123183A1 (en) 2015-08-20
CA2939339A1 (en) 2015-08-20
HK1232140A1 (zh) 2018-01-05
US20160354408A1 (en) 2016-12-08
JP2022046512A (ja) 2022-03-23
EP3104865A4 (en) 2017-11-22
EP3104865A1 (en) 2016-12-21
MX2016010293A (es) 2017-02-23
JP2017507935A (ja) 2017-03-23

Similar Documents

Publication Publication Date Title
EA201691607A1 (ru) Микроорганоиды и способы их получения и применения
JOP20200192A1 (ar) أجسام مضادة لـ tigit
EA201891202A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891201A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890050A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890049A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891199A1 (ru) Композиции, содержащие бактериальные штаммы
EA201990293A1 (ru) Мультиспецифичные антитела против cd40 и cd137
EA201791460A1 (ru) N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения
EA201692477A1 (ru) Композиции и способы применения для лечения метаболических расстройств
EA201890047A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890048A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890204A1 (ru) Антибактериальные соединения
EA201692425A1 (ru) Модифицированные биополимеры и способы их получения и использования
EA201791485A1 (ru) Анти-cd47-антитела и их применения
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201890051A1 (ru) Композиции, содержащие бактериальные штаммы
BR112017024384A2 (pt) bactérias modificadas para reduzir hiperfenilalaninemia
EA201691594A1 (ru) Циклопропиламины в качестве ингибиторов lsd1
EA201791867A1 (ru) Бициклические гетероциклы как ингибиторы fgfr4
PH12019502002A1 (en) Combination theraphy
EA201791117A1 (ru) Частичные агонисты инсулинового рецептора
EA201790405A1 (ru) Композиции и способы лечения метаболических расстройств
EA201692529A1 (ru) Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов
EA201691610A1 (ru) Анти-jagged1 антитела и способы применения